← Back to Search

Joint Replacement

MOTO Medial® UKA for Knee Arthritis

N/A
Waitlist Available
Research Sponsored by Medacta USA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be 18 years or older to participate
Subjects must have medial knee disease in the affected knee compliant with the FDA-approved indications for use of MOTO Medial® UKA
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative 2-6 weeks, 4-8 months, 9-15 months, 18-30 months and 51-69 months
Awards & highlights

Study Summary

This trial will study the long-term performance of a new type of knee surgery, comparing patient reports, clinical findings, and x-rays.

Who is the study for?
This trial is for adults over 18 with medial knee disease suitable for MOTO Medial® UKA, who can consent and comply with the study. Excluded are those with psychiatric illness, inflammatory arthritis, pregnancy, prior knee arthroplasty or infections, on immunosuppressants or narcotics, undergoing cancer treatments, or have metabolic disorders affecting bones.Check my eligibility
What is being tested?
The performance of MOTO Medial® Unicompartmental Knee Arthroplasty (UKA) is being tested through patient reports, clinical evaluations and X-rays in a prospective study across multiple centers to assess its mid-term effectiveness in treating knee conditions like osteoarthritis.See study design
What are the potential side effects?
While not explicitly listed here, typical side effects from similar procedures may include pain at the surgery site, swelling around the knee joint area post-operation which usually subsides over time. There's also a risk of implant sensitivity or allergic reaction.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My knee condition matches the FDA guidelines for MOTO Medial® UKA use.
Select...
I have never had joint replacement surgery on the affected knee.
Select...
My knee condition matches the FDA guidelines for MOTO Medial® UKA use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative 2-6 weeks, 4-8 months, 9-15 months, 18-30 months and 51-69 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative 2-6 weeks, 4-8 months, 9-15 months, 18-30 months and 51-69 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in Forgotten Joint Score
Change from baseline in Knee Alignment
Change from baseline in Knee Osteoarthritis Outcome Score
+11 more
Secondary outcome measures
Age of patient
Anesthetic
Complications
+14 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Interventional : MOTO Medial® UKAExperimental Treatment1 Intervention
Interventional : Patients who are planned to undergo a primary medial UKA using the MOTO Medial® will be enrolled.

Find a Location

Who is running the clinical trial?

Medacta USALead Sponsor
16 Previous Clinical Trials
1,811 Total Patients Enrolled
9 Trials studying Osteoarthritis
680 Patients Enrolled for Osteoarthritis
Mukesh Ahuja, MBBS, MS, CPIStudy DirectorMedacta USA

Media Library

MOTO Medial® Unicompartmental Knee Arthroplasty (Joint Replacement) Clinical Trial Eligibility Overview. Trial Name: NCT03211663 — N/A
Osteoarthritis Research Study Groups: Interventional : MOTO Medial® UKA
Osteoarthritis Clinical Trial 2023: MOTO Medial® Unicompartmental Knee Arthroplasty Highlights & Side Effects. Trial Name: NCT03211663 — N/A
MOTO Medial® Unicompartmental Knee Arthroplasty (Joint Replacement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03211663 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT03211663 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still available in this clinical research study?

"According to clinicaltrials.gov, registration for this medical study has been closed since March 29th of 2022. Nevertheless, there are currently 708 other trials seeking volunteers across the globe."

Answered by AI

What results is this trial intended to yield?

"The primary outcome of this medical trial will be the Forgotten Joint Score, which patients are assessed on at Baseline and 4-8 months post-surgery, 9-15 months, 18-30 and 51-69. Additionally, researchers will gauge Return to Work/Activity questionnaire scores (assessing ability to return to work or other activities), K & L Grading levels (OA Disease Grade in knee compartment) as well as Anesthetic type used during surgery."

Answered by AI

Who else is applying?

What state do they live in?
Indiana
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

What questions have other patients asked about this trial?

Is this replacement of the meniscus?
PatientReceived 1 prior treatment

Why did patients apply to this trial?

I'm looking for something less evasive than total knee replacement.
PatientReceived 2+ prior treatments
~43 spots leftby Aug 2025